Dear Colleague
The first update of concessionary prices were granted today for December 2023:
DrugPack SizeConcessionary Price
Acamprosate 333mg gastro-resistant tablets168£22.76
Aciclovir 800mg tablets35£3.60
Amiloride 5mg tablets28£15.70
Amisulpride 100mg tablets60£17.50
Amisulpride 200mg tablets60£30.96
Atorvastatin 10mg tablets28£1.11
Atorvastatin 20mg tablets28£1.30
Atorvastatin 40mg tablets28£1.49
Atorvastatin 80mg tablets28£3.30
Beclometasone 50micrograms/dose nasal spray200£2.63
Benzoyl peroxide 5% / Clindamycin 1% gel60£22.15
Betahistine 16mg tablets84£8.34
Betahistine 8mg tablets84£3.62
Betamethasone valerate 0.1% cream100£4.05
Bimatoprost 100micrograms/ml eye drops3£4.48
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops3£4.58
Brinzolamide 10mg/ml / Timolol 5mg/ml eye drops5£9.52
Brinzolamide 10mg/ml eye drops5£4.65
Bumetanide 1mg tablets28£2.78
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment30£9.60
Carvedilol 6.25mg tablets28£1.29
Chloramphenicol 1% eye ointment4£4.69
Clotrimazole 1% cream20£1.77
Clotrimazole 1% cream50£4.52
Clotrimazole 500mg pessaries1£9.95
Co-amilozide 5mg/50mg tablets28£10.08
Co-amoxiclav 500mg/125mg tablets21£4.38
Co-codamol 15mg/500mg tablets100£3.29
Codeine 30mg tablets28£1.08
Codeine 30mg tablets100£3.86
Cyclizine 50mg tablets100£4.35
Dexamfetamine 5mg tablets28£22.85
Docusate 50mg/5ml oral solution sugar free300£18.32
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free60£25.03
Eplerenone 50mg tablets28£4.01
Etoricoxib 60mg tablets28£3.40
Flecainide 100mg tablets60£3.25
Glycopyrronium bromide 200micrograms/1ml solution for injection ampoules10£13.32
Haloperidol 1.5mg tablets28£3.15
Hydroxocobalamin 1mg/1ml solution for injection
ampoules
5£11.89
Isotretinoin 20mg capsules30£11.21
Lamotrigine 200mg tablets56£5.74
Lamotrigine 25mg tablets56£1.95
Lamotrigine 50mg tablets56£3.48
Lamotrigine 5mg dispersible tablets sugar free28£10.05
Lansoprazole 30mg gastro-resistant capsules28£1.29
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops2.5£3.57
Letrozole 2.5mg tablets14£2.41
Levetiracetam 100mg/ml oral solution sugar free300£10.01
Lofepramine 70mg tablets56£14.25
Mebeverine 200mg modified-release capsules60£6.01
Methylphenidate 10mg tablets30£2.99
Midazolam 10mg/2ml solution for injection ampoules10£5.32
Mometasone 0.1% ointment30£4.38
Orlistat 120mg capsules84£25.36
Pantoprazole 20mg gastro-resistant tablets28£2.19
Pantoprazole 40mg gastro-resistant tablets28£2.70
Pregabalin 225mg capsules56£2.56
Prochlorperazine 5mg tablets28£1.99
Promethazine hydrochloride 10mg tablets56£17.26
Risperidone 500microgram tablets20£2.98
Ropinirole 250microgram tablets12£6.15
Ropinirole 2mg tablets28£21.73
Rosuvastatin 10mg tablets28£1.21
Rosuvastatin 40mg tablets28£1.75
Telmisartan 20mg tablets28£3.45
Terbinafine 1% cream15£3.19
Terbinafine 1% cream30£7.09
Timolol 0.25% eye drops5£1.85
Warfarin 1mg tablets28£0.80
Warfarin 3mg tablets28£0.84
Warfarin 5mg tablets28£1.75
Zolmitriptan 2.5mg orodispersible tablets sugar free6£17.52
Zolmitriptan 2.5mg tablets6£16.45
Zolmitriptan 2.5mg tablets12£32.90
Zopiclone 3.75mg tablets28£1.55
Zopiclone 7.5mg tablets28£1.60

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
CPNI has received notification that The Department of Health NI has issued correspondence dated 8 December 2023 in relation to a serious shortage protocol (SSP) in place for clarithromycin 125mg/5ml oral suspension (SSP053), extending the expiry date until Friday 15 December 2023.

BACKGROUND

  • SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
  • SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
  • Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website.
  • Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website.

ACTION

Contractors should:

  • Review the letter dated 8 December 2023 and ensure that their dispensary teams are aware of this update.
  • Note that the expiry date of the existing SSP for clarithromycin 125mg/5ml oral suspension (SSP053), has been extended to Friday 15 December 2023.
  • Note guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.

Contractors should contact their local SPPG office in the first instance should further information be required. CPNI colleagues are also available for assistance.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

*** For the Attention of Pharmacy First Sore Throat Pilot Service Providers ***
Dear Contractor
Important information regarding the Pharmacy First Sore Throat Pilot Service has been issued 12th December by SPPG.

SUMMARY

  • SPPG have issued the following correspondence 12th December 2023.
  • The monthly claim form has been updated and should be used from December 2023 onwards.
  • The claim form is available on the BSO website here.
  • All sections of the claim form should be completed.
  • The data from the claim form will be analysed and may determine future roll out of the pilot service.

ACTION

  • Contractors should read and review the correspondence issued 12th December by SPPG regarding Pharmacy First Sore Throat Pilot Service.
  • Please ensure this update in shared with relevant members of your pharmacy team.
  • The monthly claim form for December 2023 onwards has been updated.
  • All sections of the claim form should be completed and emailed to your local integrated care office for processing and payment.
  • The QR code can be offered to service-users to evaluate the service.
  • Please ensure that all relevant staff have completed the appropriate training to provide the service.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

As you will be aware, a UK-wide public consultation on Pharmacy Supervision has been launched.  The consultation will run for 12 weeks, ending on 29 February 2024 and can be accessed using the following link.

The consultation sets out proposals to amend the Medicines Act 1968 and The Human Medicines Regulations 2012. The proposals are to:

  • enable pharmacists to authorise pharmacy technicians to carry out, or supervise others carrying out, the preparation, assembly, dispensing, sale and supply of medicines;
  • allow pharmacy technicians to take primary responsibility for the preparation, assembly and dispensing of medicinal products in hospital aseptic facilities; and
  • enable pharmacists to authorise any member of the pharmacy team to hand out checked and bagged prescriptions in the absence of a pharmacist.

The first two proposals will not yet apply to Northern Ireland as Pharmacy Technicians are not currently a registered health profession here.  However, the Department of Health (NI) has established project structures to progress the regulation and registration of Pharmacy Technicians in Northern Ireland and make the necessary legislative changes to enable this.  Information on this project work can be found using the following link to the Pharmacy Technician Newsletter which will be updated by the Department on a quarterly basis.

The CPNI team will be drafting a response to this consultation and are happy to take views from contractors or for you to respond directly to the address given in the consultation documents.

The consultation closes on 29 February 2024.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

MHRA UPDATE

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Contractor
Correspondence was issued by SPPG on 08 December 2023 to advise pharmacy contractors that the Community Pharmacy Assurance Framework Visit Guidance has been updated.  The updated guidance can be viewed here.

SUMMARY

  • CPAF consists of an annual declaration completed by each community pharmacy contractor, and a visit undertaken by SPPG staff on a three yearly basis.
  • SPPG have previously advised that visits to Community Pharmacy are recommencing.
  • Pharmacies which haven’t received a visit as part of CPAF will be prioritised first as detailed in this letter issued 9th November 2023.
  • If your pharmacy is selected for a visit you will be contacted by your local office to make the necessary arrangements.

ACTIONS

  • Contractors should note the contents of the updated CPAF Visit Guidance here and share the information with relevant members of the pharmacy team.
  • Further information regarding CPAF can be found on the BSO website here.

Should contractors have any queries regarding CPAF they may wish to contact their local SPPG pharmacy adviser, or alternatively they may contact a member of the CPNI team.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive